novo nordisk glp-1 products NICE recommends new treatment from for obesity Novo Nordisk rolls out discounted

In view of this, a widespread search of SCOPUS, PubMed, and CENTRAL was performed using the following string (obesity or insulin resistance) AND (tirzepatide or Dual GIP and GLP-1 Receptor Agonist)

doi: 10.1038/s41467-020-17554-1 71 ShiimuraY.ImD.TanyR.AsadaH.KiseR.KurumiyaE.et al

T., Peng, B., Zhang, D

An intramuscular injection (IM injection) is a medical technique used to deliver medication directly into muscle tissue, where it can be absorbed quickly into the bloodstream

Whereas much of the current attention surrounding GLP-1 RAs, or glucagon-like peptide-1 receptor agonists, has been focused on their unexpected and potent effect on weight loss, one important aspect of this class of drugs should not be overlooked: GLP-1 RAs have been shown to reduce the risk of heart attack, stroke, and other major adverse cardiovascular events (MACE) in patients with type 2 diabetes who have or are at high risk for atherosclerosis